磁共振成像能否鉴别尿道旁填充剂、尿道憩室与尿道旁囊肿
回顾性分析2001至2017年50例患者共68个尿道旁囊性病变,最终诊断包括填充剂27个、尿道憩室29个、尿道旁囊肿12个,由两名腹部放射科医师盲法独立评估T1、T2及增强图像。填充剂与尿道憩室相比更常见多发、位于尿道上部或中上部、无内部液体/液平、与尿道无连接、T1等信号及T2较肌肉轻度高信号但低于尿液信号;尿道憩室平均直径大于填充剂和尿道旁囊肿(分别为24、16、15 mm)。作者认为信号强度和病变特征可显著鉴别填充剂与尿道憩室及尿道旁囊肿。
要点
- 填充剂多位于尿道上部或中上部,尿道憩室和尿道旁囊肿多位于尿道中下部。
- 填充剂T1等信号、T2较肌肉轻度高信号但低于尿液信号,且多无内部液体/液平及尿道连接。
- 尿道憩室平均直径24 mm,大于填充剂16 mm和尿道旁囊肿15 mm(P=0.005和P=0.023)。
核心结论
- 磁共振成像的信号强度和病变特征可显著鉴别尿道旁填充剂与尿道憩室及尿道旁囊肿;放射科医师在出现本文所述鉴别特征时应考虑填充剂的鉴别诊断,以避免误诊及最终不必要的手术干预。
研究设计与样本
- 回顾性研究,检索2001至2017年放射学数据库,共50例患者68个尿道旁囊性病变,最终诊断填充剂27个、尿道憩室29个、尿道旁囊肿12个;两名腹部放射科医师盲法独立评估T1、T2及增强图像;以手术和病理报告为参考标准。
关键影像表现/征象
- 填充剂较尿道憩室更常见多发(P=0.011)。
- 填充剂较尿道憩室更常见位于尿道上部或中上部(P≤0.0001)。
- 填充剂较尿道憩室更常见无内部液体/液平(P=0.002)及与尿道无连接(P=0.005)。
- 填充剂表现为T1等信号、T2较肌肉轻度高信号但低于尿液信号(P<0.0001)。
- 大多数填充剂(93%)和尿道憩室(90%)对尿道有占位效应,而尿道旁囊肿(75%)无占位效应(P<0.0001)。
诊断标准与关键数值
- 填充剂与尿道憩室鉴别:多发(P=0.011)、位于尿道上部或中上部(P≤0.0001)、无内部液体/液平(P=0.002)、与尿道无连接(P=0.005)、T1等信号及T2较肌肉轻度高信号但低于尿液信号(P<0.0001)。
- 尿道憩室平均直径24 mm,大于填充剂16 mm(P=0.005)和尿道旁囊肿15 mm(P=0.023)。
- 尿道憩室和尿道旁囊肿大多数位于尿道中下部。
临床应用与阅片要点
- 作者认为,放射科医师在出现本文所述鉴别特征时应考虑填充剂的鉴别诊断,以避免误诊及最终不必要的手术干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate magnetic resonance imaging findings that differentiate among periurethral bulking agents (primarily collagen), urethral diverticulum, and periurethral cyst.
METHODS: We searched our radiologic database retrospectively from 2001 to 2017 for periurethral cystic lesions, identifying a total of 50 patients with 68 lesions. Final diagnoses in 68 lesions were bulking agents (27), urethral diverticula (29), and periurethral cysts (12). Two abdominal radiologists, blinded to clinical history, independently evaluated T1, T2, and post-contrast images. The readers assessed number, morphological features, location, connection to urethra and mass effect, signal intensity, and enhancement for each lesion. Fisher exact test and logistic regression analysis were performed for each univariate significant feature. The operative and pathologic reports were the reference standard.
RESULTS: Magnetic resonance imaging features found more often in bulking agents versus urethral diverticulum were multiple lesions (P = 0.011), upper or upper-mid-urethral location (P ≤ 0.0001), lack of internal fluid/fluid level (P = 0.002), no urethral connection (P = 0.005), T1 isointensity, and T2 mild hyperintensity compared to muscles but lower T2 signal than urine (P < 0.0001). Most cases of urethral diverticula and periurethral cysts were detected at mid- and lower urethra. Urethral diverticula were larger than bulking agents and periurethral cysts (P = 0.005 and P = 0.023) (mean diameter = 24, 16, 15 mm, respectively). Most bulking agents (93%) and urethral diverticula (90%) showed mass effect on urethra, while periurethral cysts (75%) did not (P < 0.0001).
CONCLUSION: Signal intensity and lesion characterization on magnetic resonance imaging can significantly differentiate bulking agent from urethral diverticulum and periurethral cyst. Radiologists should consider differential diagnosis of a bulking agent, especially when distinguishing characteristics described here are present to prevent incorrect diagnosis and ultimately unnecessary surgical intervention.
引用
- Chulroek T, Wangcharoenrung D, Cattapan K, et al. Can magnetic resonance imaging differentiate among transurethral bulking agent, urethral diverticulum, and periurethral cyst? Abdom Radiol (NY). 2019. PMID: 31069481. doi:10.1007/s00261-019-02052-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。